In the quarter ended March 31, the cancer institute recorded an operating loss of $16.1 million. Last year, the cancer institute posted a $14.3 million operating loss.
In the second quarter of fiscal 2021, Dana-Farber saw its revenue year over year grow 4.6 percent to $507.8 million. The cancer institute also saw its patient revenue grow 6.7 percent year over year in the second quarter to $362 million.
The health system’s expenses also rose in the second quarter of fiscal 2021 to $523.8 million, up from $500 million recorded in the same quarter last year.
After factoring investment gains, Dana-Farber recorded a net income of $67.3 million in the second quarter of fiscal 2021. In the same period last year, Dana Farber saw a net loss of $118.1 million.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
